Paper38653243
Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors.
Jhajj HS and 8 others. Cell Chem Biol, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors. Papers, record 38653243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38653243
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epitopes | Major topic |
| Humans | |
| Animals | |
| Receptors, Tumor Necrosis Factor | |
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | |
| Receptors, OX40 | |
| Antibodies | |
| Single-Chain Antibodies | |
| Mice |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F32 GM137513 | NIGMS NIH HHS | United States | F32GM137513 | PubMed and NIH | NIH RePORTER |
| R01 AG080016 | NIA NIH HHS | United States | R01AG080016 | PubMed and NIH | NIH RePORTER |
| R35 GM136300 | NIGMS NIH HHS | United States | R35GM136300 | PubMed and NIH | NIH RePORTER |
| RF1 AG059723 | NIA NIH HHS | United States | RF1AG059723 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 38168220 | Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily. | https://conductscience.org/library/papers/38168220 |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24953012 | Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies. | Trends Immunol | 2014 | https://conductscience.org/library/papers/24953012 | PubMed |
| 2 | 28653573 | The future of immune checkpoint cancer therapy after PD-1 and CTLA-4. | Immunotherapy | 2017 | https://conductscience.org/library/papers/28653573 | PubMed |
| 3 | 28405505 | MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/28405505 | PubMed |
| 4 | 35140196 | An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35140196 | PubMed |
| 5 | 34058562 | Biparatopic single-domain antibodies against Axl achieve ultra-high affinity through intramolecular engagement. | Biochem Biophys Res Commun | 2021 | https://conductscience.org/library/papers/34058562 | PubMed |
| 6 | 25169849 | TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future. | Cytokine Growth Factor Rev | 2014 | https://conductscience.org/library/papers/25169849 | PubMed |
| 7 | 33424853 | Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening. | Front Immunol | 2020 | https://conductscience.org/library/papers/33424853 | PubMed |
| 8 | 23980122 | Fcγ receptors enable anticancer action of proapoptotic and immune-modulatory antibodies. | J Exp Med | 2013 | https://conductscience.org/library/papers/23980122 | PubMed |
| 9 | 32698317 | Monoclonal Antibodies in Cancer Therapy. | Antibodies (Basel) | 2020 | https://conductscience.org/library/papers/32698317 | PubMed |
| 10 | 29183788 | Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries. | J Mol Biol | 2018 | https://conductscience.org/library/papers/29183788 | PubMed |
| 11 | 31573956 | An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31573956 | PubMed |
| 12 | 25996440 | New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma. | Sci Rep | 2015 | https://conductscience.org/library/papers/25996440 | PubMed |
| 13 | 27192570 | Targeting T Cell Co-receptors for Cancer Therapy. | Immunity | 2016 | https://conductscience.org/library/papers/27192570 | PubMed |
| 14 | 34274536 | The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains. | Mol Ther | 2021 | https://conductscience.org/library/papers/34274536 | PubMed |
| 15 | 26274600 | Advances in Antibody Design. | Annu Rev Biomed Eng | 2015 | https://conductscience.org/library/papers/26274600 | PubMed |
| 16 | 31894001 | Development of therapeutic antibodies for the treatment of diseases. | J Biomed Sci | 2020 | https://conductscience.org/library/papers/31894001 | PubMed |
| 17 | 36344331 | Unlocking the potential of agonist antibodies for treating cancer using antibody engineering. | Trends Mol Med | 2023 | https://conductscience.org/library/papers/36344331 | PubMed |
| 18 | 12536217 | Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. | Nat Biotechnol | 2003 | https://conductscience.org/library/papers/12536217 | PubMed |
| 19 | 30917623 | Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology. | Molecules | 2019 | https://conductscience.org/library/papers/30917623 | PubMed |
| 20 | 33082574 | Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2. | Nat Chem Biol | 2021 | https://conductscience.org/library/papers/33082574 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42547263 | Efficient discovery of an agonistic anti-OX40 nanobody by epitope-directed approach to address enrichment-driven epitope bias. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42547263 | PubMed |
| 42218135 | A simple and broadly applicable nanobody-based approach to generate potent TNFR agonists. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42218135 | PubMed |
| 41561762 | OX40/OX40L: a new target for tumor immunotherapy and its clinical research progress. | Front Oncol | 2025 | https://conductscience.org/library/papers/41561762 | PubMed |
| 39673023 | The Evolving Applications of Bispecific Antibodies: Reaping the Harvest of Early Sowing and Planting New Seeds. | BioDrugs | 2025 | https://conductscience.org/library/papers/39673023 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TNFRSF4 | 7293 | PubTator's text mining | https://conductscience.org/library/genes/7293 | NCBI Gene |
| TNFRSF9 | 3604 | PubTator's text mining | https://conductscience.org/library/genes/3604 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | PP358776–PP358779 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38653243
GET https://conductscience.org/api/papers/v1/38653243/references?page=2